Overview Fundamentals API Earnings EOD API Sample Code Pricing

Anavex Life Sciences Corp (AVXL NASDAQ) stock market data APIs

$5.05 -0.34(-6.3%) as of July 12, 2024
Price chart is built with Anychart

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Anavex Life Sciences Corp Financial Data Overview

5.39
5.05
-
5.435
5.02
3.25-10.45
456 M
84 642 K
0
-0.13
0.634
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AVXL',
Type: 'Common Stock',
Name: 'Anavex Life Sciences Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000C9K8K4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1314052',
EmployerIdNumber: '98-0608404',
FiscalYearEnd: 'September',
IPODate: '2006-08-02',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Anavex Life Sciences Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.5
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Anavex Life Sciences Corp Earnings via APIs

  • Latest Release 2024-06-18
  • EPS/Forecast -0.11

Get Anavex Life Sciences Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com